Callan Capital LLC Grows Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Callan Capital LLC boosted its stake in The Procter & Gamble Company (NYSE:PG) by 51.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,654 shares of the company’s stock after acquiring an additional 2,265 shares during the period. Callan Capital LLC’s holdings in Procter & Gamble were worth $1,080,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of PG. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors grew its position in Procter & Gamble by 122.3% during the first quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 9,855 shares of the company’s stock worth $1,599,000 after buying an additional 5,422 shares during the period. AA Financial Advisors LLC purchased a new position in shares of Procter & Gamble during the first quarter valued at approximately $1,079,000. BI Asset Management Fondsmaeglerselskab A S lifted its stake in shares of Procter & Gamble by 3.7% during the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 431,679 shares of the company’s stock valued at $70,040,000 after buying an additional 15,329 shares during the period. Boomfish Wealth Group LLC lifted its stake in shares of Procter & Gamble by 2.2% during the first quarter. Boomfish Wealth Group LLC now owns 5,075 shares of the company’s stock valued at $823,000 after buying an additional 111 shares during the period. Finally, Pictet North America Advisors SA increased its position in Procter & Gamble by 12.7% during the first quarter. Pictet North America Advisors SA now owns 21,533 shares of the company’s stock worth $3,494,000 after purchasing an additional 2,422 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CEO R. Alexandra Keith sold 855 shares of the business’s stock in a transaction that occurred on Monday, April 22nd. The stock was sold at an average price of $158.50, for a total transaction of $135,517.50. Following the transaction, the chief executive officer now directly owns 4,004 shares of the company’s stock, valued at $634,634. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, insider Moses Victor Javier Aguilar sold 9,149 shares of the stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $167.72, for a total transaction of $1,534,470.28. Following the completion of the transaction, the insider now directly owns 12,929 shares of the company’s stock, valued at $2,168,451.88. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the completion of the sale, the chief executive officer now directly owns 4,004 shares of the company’s stock, valued at $634,634. The disclosure for this sale can be found here. Insiders have sold 154,544 shares of company stock valued at $25,413,051 in the last ninety days. Company insiders own 0.17% of the company’s stock.

Procter & Gamble Stock Up 0.7 %

NYSE PG traded up $1.14 on Wednesday, reaching $166.80. The company had a trading volume of 4,982,245 shares, compared to its average volume of 6,527,757. The stock has a market capitalization of $393.67 billion, a P/E ratio of 27.13, a P/E/G ratio of 3.18 and a beta of 0.41. The company’s fifty day moving average is $165.97 and its 200 day moving average is $159.85. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $169.41. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.10. The company had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm’s quarterly revenue was up .6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.37 EPS. Sell-side analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be issued a dividend of $1.0065 per share. The ex-dividend date is Friday, July 19th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.41%. Procter & Gamble’s dividend payout ratio is 65.85%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on PG. Barclays increased their price objective on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 23rd. BNP Paribas started coverage on shares of Procter & Gamble in a report on Monday, June 24th. They issued an “outperform” rating and a $187.00 price target for the company. StockNews.com raised shares of Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Tuesday, June 25th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a research note on Monday, April 22nd. Finally, Argus boosted their price target on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Thursday, April 25th. Six equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus target price of $170.72.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.